This book bridges the gap between advances in basic biology and chemistry and technological applications in the field of toxicity assessments. It describes areas of progress in the laboratory and clinic and discusses aspects of cellular organelles. It also covers the basic principles and applications of modern toxicological tools such as transcriptomic, proteomic, and metabolomic approaches. The recent developments on molecular modeling and systems biology are described with an eye on the future establishment of virtual cell technology. Finally the clinical implications for the understanding of acute and chronic renal toxicity are studied.

Kidney Disease: From advanced disease to bereavement provides guidance to renal and palliative care professionals dealing with patients with advanced kidney disease, who are approaching end of life. The book describes the tools used to achieve a good death including advance care planning, symptom control law and ethics, recognizing dying, withdrawal of treatment, and a holistic approach to patient care. By using case histories, the book highlights how to facilitate good communication between patients, families and their renal and palliative teams. There are also chapters on support for carers and bereavement. Revised and updated, this new edition is written in a bullet point style to provide an indispensable guide to the day-to-day management of patient care. This pocketbook will be an essential guide for nephrologists, renal nurses, nephrologist trainees, and doctors and nurses working in palliative care.

THE WISDOM OF AN IMPOSSIBLE ORGANIZATION
"Again, may I say, how profoundly I admire your work and how deeply gratifying it is for me to hear that you appreciate mine."
--Peter F. Drucker in a letter to Aravind's founder, Dr. V

When a crippling disease shattered his lifelong ambition, Dr. V (Venkataswamy) chose an impossible new dream: to cure the world of blindness. The tiny clinic he founded in India defied conventional business logic and is now the largest provider of eye care on the planet.

At Aravind, patients choose whether to pay or not. Millions are treated for free, yet the organization remains stunningly self-reliant. Serving everyone from penniless farmers to the president, it delivers world-class outcomes at less than a hundredth of what similar services cost in advanced nations. Its model is emulated by organizations everywhere from Rwanda to San Francisco.

"Infinite Vision" uncovers the radical principles behind Aravind's baffling success. Charged with profound insights and stories, it draws readers to the heart of Dr. V's selfless vision, proving how choices that seem quixotic can, when executed with compassion and integrity, yield incredible results--results that can light the eyes of millions.

"Reveals the power of a model that combines business discipline with compassion. May the wisdom of Dr. V and Aravind shared here inspire many such initiatives for the well-being of future generations."
--Muhammad Yunus, Nobel Peace Prize Laureate and founder, Grameen Bank
"A must-read for anyone interested in leadership, service, and the building of institutions that release the best energies of the human spirit."
--Jacqueline Novogratz, founder and CEO, Acumen Fund, and author of The Blue Sweater
"Aravind may be a case study for MBA students and a model social business, but to me this book told a story with elegance, clarity, and intimacy."
--Fred de Sam Lazaro, Correspondent, PBS NewsHour
"In the world of blindness Dr. V has performed a miracle."
--Ram Dass, author of Be Here Now and cofounder, Seva Foundation

One hundred percent of the authors' royalties are being gifted to Aravind's sight-restoring work.

Revised in line with feedback from users of the first edition, this practical clinical resource boasts a worldwide array of contributors, including the most prominent pediatric nephrologists in the US.

Excellently illustrated with photomicrographs and clinical diagrams supporting the chapters, Clinical Pediatric Nephrology features expanded case histories relating to the discussion and management of renal disease thus ensuring that this is a highly useful reference tool for nephrologists and house officers in practice, as well as nephrology fellows in training.

This work offers a comprehensive reference guide to help clinicians in the field of Internal Medicine addressing common aspects of endocrinological disorders in their daily practice. The exponential growth in our knowledge of biomedicine calls for continuous multidisciplinary approaches across specialists and disciplines. In this volume, recognized experts in each given area explore the complex mechanisms linking endocrinological disorders to abnormalities of the cardiovascular system, kidney, liver and gastrointestinal tract, autoimmune, neuro-psychiatric, rheumatic, and dermatologic diseases. Aspects connected to critically ill and elderly patients are examined as well, helping to enhance daily interactions with the most fragile populations observed in clinical medicine. The individual chapters are designed to deliver timely information while explaining pathophysiological mechanisms with the help of figures, flow-charts, and updated guidelines. The book offers a unique and valuable resource for all clinicians, residents, specialists, and physicians involved daily in the management of complex and multidisciplinary systemic diseases.

This reference work provides a comprehensive review of the most crucial and provocative aspects of pancreas transplantation. It represents a unique source of information and guidance for the current generation of transplant surgeons that evolved from being pure clinicians into savvy administrators knowledgeable in every regulatory aspect governing transplantation. The book contains 15 chapters covering every single aspect of the surgical operation in the donors as well as the recipients of pancreas transplants. The pre-operative workup, as well as the post-operative immunosuppression management, and the treatment of recurrent diseases are addressed in detail. In addition, the book further expands the role of islet cell transplant with its ever increasing prominence, which includes the role of autologous islet cell transplant. The impact of increasing regulatory burdens from the federal government coupled with the economic and health burden of Diabetes mellitus is discussed.